Teva Pharmaceutical Industries Ltd. ADR 1.42% $19.56B ...

The plans are for powering the nearby GSK factory, but Historic Environment Scotland, National Air Traffic Services and ...

South African sim racing extraordinaire, David Perel, clarifies its meteoric rise and what influence it'll have on future ...

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

A phase 3 trial of GSK’s linerixibat in a liver disease has hit its primary endpoint, keeping the drugmaker on track to launch the first treatment for the relentless itching experienced by some ...

DualityBio entered into an exclusive $1 billion option agreement with GSK for DB-1324. Thermo Fisher Scientific completed its ...

LONDON — A blood cancer treatment from GSK helped patients live longer in a pivotal trial, a significant finding as the once-withdrawn drug mounts a comeback. In the study, a treatment ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

But, increased costs became a drag on net income in 2023 as firms invested in technology and infrastructure. Further ...

GSK is now looking to start a phase 3 trial in the first-line setting shortly, Abdullah said. The DREAMM-10 study will once again pit Blenrep against Darzalex, this time as part of front-line ...